|
EQRX
|
EQRx, Inc.
|
0.83%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.82%
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
0.80%
|
US
|
NYSE
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.79%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
0.79%
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
0.79%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.78%
|
US
|
NASDAQ
|
|
IMGO
|
Imago BioSciences, Inc
|
0.73%
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
0.72%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.68%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
RNA
|
Avidity Biosciences, Inc.
|
0.65%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
0.61%
|
CA
|
TSX
|
|
RGNX
|
REGENXBIO Inc.
|
0.60%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
0.59%
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
0.59%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.58%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.58%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.57%
|
US
|
NASDAQ
|